Johns Hopkins Institute for NanoBioTechnology: Could This New Hydrogel Make HIV Therapy More Convenient?
September 26, 2023
September 26, 2023
BALTIMORE, Maryland, Sept. 26 (TNSres) -- Johns Hopkins Institute for NanoBioTechnology issued the following news:
A new injectable solution that self-assembles into a gel under the right conditions could help manage HIV unlike any currently available methods, researchers have found.
The gel releases a steady dose of the anti-HIV drug lamivudine over six weeks, suggesting people living with HIV could have new therapy that doesn't require a daily pill regimen to prevent . . .
A new injectable solution that self-assembles into a gel under the right conditions could help manage HIV unlike any currently available methods, researchers have found.
The gel releases a steady dose of the anti-HIV drug lamivudine over six weeks, suggesting people living with HIV could have new therapy that doesn't require a daily pill regimen to prevent . . .